The European Society for Vascular Surgery (ESVS) has prepared new guidelines for the
treatment of patients with CVD, to update the existing ESVS guidelines on the management …

These guidelines will be updated every four years. Vascular centres are encouraged to audit
implementations made as a result of the guidelines. Audit cycles should be repeated and …

Aims Long-term sequelae may occur after SARS-CoV-2 infection. We comprehensively
assessed organ-specific functions in individuals after mild to moderate SARS-CoV-2 …

The direct oral anticoagulants (DOACs), dabigatran, rivaroxaban, apixaban, and edoxaban,
are becoming the most commonly prescribed drugs for preventing ischemic stroke in …

Fondaparinux sodium is a chemically synthesized selective factor Xa inhibitor approved for
the prevention and treatment of venous thromboembolic events, that is, deep vein …

BACKGROUND: The optimal duration of anticoagulation therapy for isolated distal deep
vein thrombosis in patients with cancer is clinically relevant, but the evidence is lacking. The …

Background There has been limited data on anticoagulation strategies and long-term
recurrence in patients with venous thromboembolism (VTE) in the era of direct oral …

Objective Currently, there is no consensus on the optimal management of Paget-Schroetter
syndrome (PSS). Our objective was to summarise current evidence for management of PSS …

Catheter-directed thrombolysis (CDT) has been utilized as an adjunct to anticoagulant
therapy in selected patients with deep vein thrombosis (DVT) for approximately 30 years …

Objectives Primary deep vein thrombosis of the upper extremity (UEDVT) is a rare condition
but up to 60% of patients may develop post‐thrombotic syndrome in the upper extremity (UE …